Allogene Therapeutics Inc
NASDAQ:ALLO

Watchlist Manager
Allogene Therapeutics Inc Logo
Allogene Therapeutics Inc
NASDAQ:ALLO
Watchlist
Price: 2.68 USD -0.37%
Updated: May 22, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

-227m
+5%
Operating Cash Flow
Growth Rates:
1 Year
-4%
3 Years
-84%
5 Years
-203%
7 Years
-
10 Years
-
72.5m
-56%
Investing Cash Flow
Growth Rates:
1 Year
-70%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
95.6m
-0.1%
Financing Cash Flow
Growth Rates:
1 Year
+3 232%
3 Years
-85%
5 Years
-88%
7 Years
-
10 Years
-

Cash Flow Statement
Allogene Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
(212)
(241)
(147)
(154)
(185)
(207)
(227)
(243)
(250)
(229)
(239)
(251)
(257)
(304)
(308)
(313)
(333)
(351)
(355)
(333)
(327)
(294)
Depreciation & Amortization
2
2
3
4
5
6
7
8
8
7
8
8
10
12
14
15
14
14
14
14
14
14
Change in Deffered Taxes
0
(0)
(0)
(0)
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
19
26
38
51
46
52
58
63
65
68
72
75
81
86
88
88
84
80
74
68
66
59
Other Non-Cash Items
153
161
55
42
49
56
63
67
74
80
86
90
94
101
100
101
94
87
81
74
91
79
Change in Working Capital
12
2
(4)
0
(7)
(3)
7
12
54
18
7
3
(32)
(13)
(12)
(7)
4
31
22
(1)
(15)
(27)
Cash from Operating Activities
(45)
N/A
(75)
-68%
(94)
-25%
(109)
-16%
(137)
-27%
(148)
-8%
(150)
-1%
(155)
-4%
(115)
+26%
(124)
-7%
(138)
-12%
(149)
-8%
(185)
-24%
(204)
-10%
(205)
-1%
(204)
+1%
(221)
-8%
(219)
+1%
(238)
-9%
(246)
-3%
(238)
+3%
(227)
+5%
Investing Cash Flow
Capital Expenditures
(3)
(14)
(21)
(38)
(51)
(53)
(61)
(63)
(66)
(60)
(55)
(38)
(21)
(17)
(7)
(4)
(5)
(4)
(3)
(3)
(2)
(0)
Other Items
(630)
(586)
(532)
(119)
215
169
(296)
(457)
(439)
(333)
115
195
185
61
81
90
111
246
208
148
165
73
Cash from Investing Activities
(633)
N/A
(600)
+5%
(553)
+8%
(157)
+72%
164
N/A
116
-29%
(357)
N/A
(519)
-45%
(505)
+3%
(393)
+22%
60
N/A
157
+160%
164
+4%
44
-73%
74
+66%
86
+16%
106
+24%
241
+127%
205
-15%
145
-29%
163
+12%
72
-56%
Financing Cash Flow
Net Issuance of Common Stock
654
655
503
346
59
75
675
677
634
623
26
25
12
8
5
3
3
3
92
96
96
96
Net Issuance of Debt
117
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
771
N/A
772
+0%
620
-20%
347
-44%
59
-83%
75
+27%
675
+801%
677
+0%
634
-6%
623
-2%
26
-96%
25
-6%
12
-51%
8
-35%
5
-41%
3
-29%
3
-8%
3
-3%
92
+3 118%
96
+3%
96
+0%
96
0%
Change in Cash
Net Change in Cash
94
N/A
97
+4%
(27)
N/A
81
N/A
86
+6%
43
-50%
168
+289%
2
-99%
13
+487%
106
+693%
(52)
N/A
32
N/A
(9)
N/A
(152)
-1 549%
(127)
+16%
(115)
+9%
(111)
+3%
25
N/A
59
+131%
(5)
N/A
21
N/A
(59)
N/A
Free Cash Flow
Free Cash Flow
(48)
N/A
(89)
-85%
(115)
-30%
(147)
-28%
(188)
-28%
(201)
-7%
(211)
-5%
(218)
-4%
(181)
+17%
(184)
-2%
(193)
-5%
(187)
+3%
(206)
-10%
(221)
-7%
(212)
+4%
(208)
+2%
(226)
-8%
(223)
+1%
(241)
-8%
(249)
-3%
(239)
+4%
(227)
+5%

See Also

Summary
ALLO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALLO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALLO stock valuation using valuation multiples.
Wall Street Estimates
ALLO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALLO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.